Nursing grand rounds: Multiple sclerosis

Journal of Neuroscience Nursing

Volumn 37, Issue 1, 2005, Pages 15-19

  Holland, Nancy J ^a   Madonna, Michele ^a  

^a National Multiple Sclerosis Society   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CASE REPORT; FEMALE; HUMAN; METHODOLOGY; MULTIPLE SCLEROSIS; NURSING; NURSING DISCIPLINE; NURSING EDUCATION; PATHOPHYSIOLOGY; REVIEW;

ADULT; EDUCATION, NURSING, CONTINUING; FEMALE; HUMANS; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; SPECIALTIES, NURSING;

EID: 17844372717     PISSN: 08880395     EISSN: None     Source Type: Journal    
DOI: 10.1097/01376517-200502000-00003     Document Type: Article

References (24)

1. Andersen, J.T., & Bradley, W.E. (1976). Bladder and urethral innervation in multiple sclerosis. British Journal of Urology, 48, 193-198.
2. Blaivas, J.G., Bhimani, G., & Labib, K.B. (1979). Vesicourethral dysfunction in multiple sclerosis. Journal of Urology, 122, 342-347.
3. Chia, Y.W., Fowler, C.J., Kamm, M.A., Henry, M.M., Lemieux, M.C., & Swash, M. (1995). Prevalence of bowel dysfunction in patients with multiple sclerosis and bladder dysfunction. Journal of Neurology, 242(2), 105-108.
4. Fisk, J.D., Pontefract, A., Ritvo, P.G., Archibald, C.J., & Murray, T.J. (1994). The impact of fatigue on patients with MS. Canadian Journal of Neurological Science, 21, 9-14.
5. Fowler, C.J., & Henry, M.M. (1999). Gastrointestinal dysfunction in multiple sclerosis. International Journal of Multiple Sclerosis Care, 6, 59-61.
6. Frankel, D. (2001). Multiple sclerosis. In D. Umphred (Ed.), Neurological rehabilitation (4th ed., pp. 595-615). St. Louis: Mosby.
7. Freal, J.F., Kraft, G.H., & Coryell, J.K. (1984). Symptomatic fatigue in MS. Archives of Physical Medicine and Rehabilitation, 65, 135-138.
8. Frohman, E. (1999). Vision. In S. van den Noort & N. Holland (Eds.), Multiple sclerosis in clinical practice (pp. 8-97). New York: Demos.
9. Goldstein, I., Siroky, M.B., Sax, D.S., & Krane, R.J. (1982). Neurologic abnormalities in multiple sclerosis. Journal of Urology, 128, 541-545.
10. Halper, J. (2002). Complementary and alternative therapies. In J. Halper & N. Holland (Eds.), Comprehensive nursing care in multiple sclerosis (2nd ed., pp. 183-189). New York: Demos.
11. Hinds, J.P., Eidelman, B.H., & Wald, A. (1990). Prevalence of bowel dysfunction in multiple sclerosis: A population survey. Gastroenterology, 98, 1538-1542.
12. Holland, N. (1999). Bowel management. In S. van den Noort & N. Holland (Eds.), Multiple sclerosis in clinical practice (pp. 44-45). New York: Demos.
13. Holland, N., & Halper, J. (1999). Primary care management of multiple sclerosis. ADVANCE for Nurse Practitioner, 7(3), 26-32, quiz 33-34.
14. Lublin, F., & Reingold, S. (1996). Defining the course of multiple sclerosis: Results of an international survey. Neurology, 46, 907-911.
15. Maloni, H. (2000). Pain in multiple sclerosis. Clinical Bulletin, National Multiple Sclerosis Society.
16. Murray, T.J. (1985). Amantadine therapy for fatigue in MS. Canadian Journal of Neurological Science, 12, 251-254.
17. Namey, M. (2002). Management of elimination dysfunction. In J. Halper & N. Holland (Eds.), Comprehensive nursing care in multiple sclerosis (2nd ed., p. 45). New York: Demos.
18. National Multiple Sclerosis Society. (2003). Expert opinion paper: Disease management consensus statement, 2003. New York: Author.
19. Nordenbo, A., & Andersen, J. (1996). Disturbance of anorectal function in multiple sclerosis. Journal of Neurology, 243, 445-451.
20. Pignotti, M., & Holland, N. (1998). Complementary medicine. In N. Holland & J. Halper (Eds.), Multiple sclerosis: A self-care guide to wellness (pp. 13-1-13-5). Washington, DC: Paralyzed Veterans of America.
21. Sadovnick, A.D., Eisen, K., Ebers, G.C., & Paty, D.W. (1991). Cause of death in patients attending multiple sclerosis clinics. Neurology, 41, 1193-1196.
22. Schapiro, R. (2003). Symptomatic management in multiple sclerosis (4th ed.). New York: Demos.
23. Schoenberg, H.W., & Gutrich, J.M. (1980). Management of vesical dysfunction in multiple sclerosis. Urology, 16, 144.
24. van den Noort, S. (1999). Treatments to reduce disease progression and disability. In S. van den Noort & N. Holland (Eds.), Multiple sclerosis in clinical practice (pp. 23-33). New York: Demos.